
GC61100
mTOR inhibitor-7
Also known as 4-(difluoromethyl)-5-[4-[(3S,5R)-3,5-dimethylmorpholin-4-yl]-6-[(3R)-3-methylmorpholin-4-yl]-1,3,5-triazin-2-yl]pyridin-2-amine
mTOR inhibitor-7, a rapamycin derivative, is a potent, selective, orally active, and brain-penetrant mTOR inhibitor, with an IC50 and Ki of 5 nM and 3·6 nM, respectively
ChemicalCAS1927857-98-4MW435.47FormulaC20H27F2N7O2
- CAS number
- 1927857-98-4
- Molecular weight
- 435.47
- Formula
- C20H27F2N7O2
- Solubility
- DMSO: 100 mg/mL (229·64 mM)
- InChIKey
- YXQKBQLVKBUCLZ-UPJWGTAASA-N
- Catalogue number
- GC61100
- Brand
- GLPBIO
Computed properties PubChem CID 121334440 · XLogP 2.3 · TPSA 103 Ų · H-bond donors 1
- XLogP
- 2.3
- TPSA
- 103 Ų
- H-bond donors
- 1
- H-bond acceptors
- 11
- Rotatable bonds
- 4
- Heavy atoms
- 31
SMILES C[C@@H]1COCCN1C2=NC(=NC(=N2)C3=CN=C(C=C3C(F)F)N)N4[C@@H](COC[C@@H]4C)C
Computed descriptors from PubChem (CID 121334440), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il